154 assets in Colon Carcinoma

Therapeutic assets addressing Colon Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Elzocabtagene Autoleucel Vector (Anti-Gcc Car) Colon Carcinoma	The Affiliated Hospital of Qingdao University	N/A	D (28)
Icg-Nanocoll Colon Carcinoma	University Hospital, Ghent	N/A	D (28)
Luminomark Inj. 0. Colon Carcinoma	Seoul St. Mary's Hospital	N/A	NR ()
Oncovax Colon Carcinoma	Vaccinogen Inc	P3	NR ()

Showing 151 to 154 of 154 assets

PreviousPage 4 of 4Next